| BMYBristol Myers Squibb | KYMRKymera Therapeutics, Inc. | NRIXNurix Therapeutics, Inc. | SLSSELLAS Life Sciences Group, Inc. | ZBIOZenas BioPharma, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 7/10 | 10/10 | 5/10 | 10/10 | 2/10 |
| Price | $55.00 | $116.46 | $22.46 | $10.53 | $24.67 |
| 1 month | -7.50% | +44.19% | +29.23% | +29.68% | +31.71% |
| 1 year | +23.08% | +147.05% | +87.64% | +494.92% | +146.21% |
| 5 year | +0.48% | +144.36% | -24.30% | -8.12% | - |
| P/E (TTM) | 15.4 | -30.4 | -7.9 | -70.3 | -3.7 |
| P/E vs sector | -43% | - | - | - | - |
| Market cap | $110.3B | $9.6B | $2.3B | $2.1B | $1.6B |
| Sector | Health Care | Healthcare | Healthcare | Healthcare | Healthcare |